John Lewicki
Fortune : 31 932 $ au 31/05/2026
Fortune : 31 932 $ au 31/05/2026
John A. Lewicki is Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Formerly, Dr. Lewicki was President, Chief Executive Officer & Director at Mereo BioPharma 5, Inc. from 2018 to 2019.
Prior to that, Dr. Lewicki was Principal at Scios, Inc. from 1983 to 2000.
Dr. Lewicki earned a doctorate from the University of California San Diego.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2026 | 464 130 ( 0,06 % ) | 31 932 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Directeur Technique/Scientifique/R&D | 01/07/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Directeur Général | 23/04/2019 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Directeur Technique/Scientifique/R&D | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national